Indian Patent Law | Intellepedia

Squibb Secures Interim Injunction Against Zydus in Nivolumab Patent Dispute

Laboratory pipette with DNA and molecular structures representing biotech research

The Delhi High Court has issued an interim injunction restraining Zydus from launching its Nivolumab biosimilar, siding with Squibb’s claim of imminent patent infringement.

Delhi HC Remands Oxidation Process Patent Rejection, Cites Invalid Section 2(1)(j) and 59 Findings

Green chalkboard with various hand-drawn organic chemistry structures and chemical equations, including benzene rings, hydroxyl groups, and molecular formulas like N₂ + 3H₂ → 2NH₃, representing chemical reactions and compounds.

In the case of Treibacher Industrie AG v. Assistant Controller of Patents, the Delhi High Court set aside the refusal of a patent application for a catalytic oxidation process. It held that the amended claims qualified as a process invention and were within the permissible scope of amendment under Section 59.

Court Awards ₹50 Lakh to GSP Crop Science in Patent Infringement Case Over Agrochemical Formula

Wooden letter tiles arranged to spell "SELLER LIABILITY," highlighting the concept of seller liability in Patent infringement cases

Delhi HC orders ₹50 lakh in damages to GSP Crop Science for patent infringement in agrochemicals, affirming seller liability under Indian patent law.

Patented Biologics and Section 104A: No Process Disclosure Without Proving Product Identity

An image with the title "Biosimilars & Section 104A" written in a mixed-font, ransom-note style on a blue background. To the right, various colorful pills and tablets are spilling out of an orange prescription pill bottle.

Roche sued Zydus for infringing its process patent on Pertuzumab. The Delhi High Court held that Roche had not shown Zydus’s biosimilar was identical to its product. Without identity, Section 104A did not apply, and the Court refused to compel Zydus to disclose its manufacturing process.

Who Bears the Patent Credibility Challenge Burden?

A photo featuring Auguste Rodin's sculpture The Thinker positioned outdoors against a backdrop of green trees and blue sky. On the left side, there is a dense leafy tree, while on the right, a classical stone building with columns is partially visible.

Mold Tek filed a case for infringement of its patents relating to tamper-proof plastic lids, and secured an interim injunction. The Commercial Court vacated the injunction, placing the burden of establishing validity on the patentee. The Delhi High Court reversed this, clarifying that it is the defendant’s burden to raise a credible invalidity defence under Section 107.

Patent Application for System to Locate Users on P2P Networks Refused under Section 3(k)

Wooden cylinders with letters "P2P" symbolizing peer-to-peer networks, placed on a background of dollar bills. Wooden cylinders with letters "P2P" symbolizing peer-to-peer networks, placed on a background of dollar bills.

The Delhi High Court has upheld the refusal of a patent application for a system that locates users on peer-to-peer networks. The Court ruled that the invention was a computer program per se, excluded from patentability under Section 3(k) of the Patents Act.

Ziegler-Natta Catalyst Patent Rejection Upheld for Lack of Inventive Step

Illustration of a judge at a courtroom bench holding a gavel, smiling and giving a thumbs down, with a speech bubble saying “This is ‘Natta’ Catalyst” – a pun referring to the rejection of a Ziegler-Natta catalyst patent.

The Delhi High Court upheld the refusal of Lummus Novolen’s patent for a Ziegler-Natta catalyst, citing lack of inventive step and similarity to prior art. Read the key observations and legal reasoning.

Patent on Carbon Capture Process freed from IPO refusal

A dark carbon footprint symbol is imprinted on a vibrant green grass background, representing the capture of carbon by nature.

The Madras High Court has overturned the rejection of a patent on a carbon capture process, citing the Patent Office’s failure to adequately justify its decision and its reliance on new, unaddressed grounds. The Court remanded the case for a fresh hearing with a focus on technical and economic evaluations.

Akebia’s patent for Anemia therapy gets fresh blood from Court

Illustration featuring the headline “Court infuses fresh blood into Patent for Anemia Therapy” alongside an image of a blood bag with a red tube.

In a recent case the Madras High Court upheld Akebia Therapeutics’ appeal on its anaemia treatment patent, interpreting Section 59 to allow claim amendments from treatment methods to compositions, as long as they’re disclosed in the original application. The case underscores the significance of well-documented specifications in pharmaceutical patents.

Blackberry’s Patent Refusal Set Aside by Delhi High Court

City skyline at night with glowing Wi-Fi symbols and connection lines, representing wireless communication and smart city connectivity

The Delhi High Court has set aside the Indian Patent Office’s refusal of Blackberry’s communication patent application. Citing a lack of reasoning and violation of natural justice principles, the Court directed a fresh evaluation of the amendments and remaining objections under the Patents Act.